ICAP

Eswatini

(Swaziland)

Eswatini (Swaziland)

In the last decade, Eswatini has cut its rate of new HIV infections in half, according to the SHIMS (Swaziland HIV Incidence Measurement Survey) and SHIMS2 national population-based HIV impact assessment surveys conducted by the Ministry of Health and ICAP. The SHIMS 3 survey will soon determine further progress towards global HIV targets.

ICAP’s work in Eswatini is longstanding as a key technical and implementation partner for projects focusing on the prevention of maternal-to-child transmission (PMTCT), early infant diagnosis, HIV drug resistance surveillance, laboratory improvement, and ongoing training of health care workers, epidemiologists, and researchers.

ICAP in Eswatini also works in collaboration with the Eswatini Ministry of Health and Family Life Association of Eswatini to conduct clinical trials with investigational drugs and registered products through the Eswatini Prevention Center Clinical Research Site as part of ICAP’s Clinical Trials Unit. The clinical research is implemented in close collaboration with local stakeholders to strengthen clinical research systems and conduct studies that impact local and global public health programs. Over 2,400 participants from diverse populations have been enrolled in CRS studies and participated in studies relating to HIV prevention with oral and injectable pre-exposure prophylaxis (PrEP), COVID-19 vaccination, and HPV vaccination.

Projects

CoVPN 3008: UBUNTU Study

  • current
The UBUNTU study is a research study evaluating the Moderna COVID-19 mRNA vaccine. We already know that this vaccine prevents COVID-19 disease, including severe COVID-19. The United States and many other countries use the Moderna vaccine. We want to know how many doses of vaccine are needed for protection against COVID-19 for adults living with ...

HPTN 084 OLE Study

  • current
A Phase 3 Double-Blind Safety and Efficacy Study of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women Link: https://www.hptn.org/research/studies/hptn084 ...

HPV Vaccine Study

  • current
A Randomized Non-Inferiority Study to Assess Immunogenicity, Safety, and Acceptability of Two vs. Three Doses of the Nonavalent Human Papillomavirus (HPV) Vaccine Among Children, Adolescents and Young Adults Living with HIV in Eswatini ...

INSIGHT Cohort

  • current
A prospective, observational, open-label cohort study to evaluate daily oral PrEP uptake, adherence, persistence and preferences for attributes of PrEP among young women (18-30 y) ...

Population-based HIV Impact Assessment (PHIA)

  • Multi-Country,
  • current:
  • Cameroon
  • ,
  • Cote d’ Ivoire
  • ,
  • Democratic Republic of the Congo
  • ,
  • Eswatini
  • ,
  • Lesotho
  • ,
  • Malawi
  • ,
  • Tanzania
  • ,
  • Uganda
PHIA is a multi-country initiative led by ICAP, the U.S. Centers for Disease Control and Prevention (CDC), and ministries of health in PEPFAR-supported countries. Each survey offers household-based HIV counseling and testing conducted by trained survey staff, with return of results. The surveys also ask questions about access to preventive care and treatment services for adults and children. The results measure national and regional progress toward UNAIDS’ 90-90-90 goals and guide policy ...

Resolve to Save Lives

  • Multi-Country,
  • current
ICAP has launched a multi-country emergency response training initiative to prepare health care workers on the front lines of the COVID-19 response. The training will build the competence and confidence of frontline health care workers to safely identify, report and support people with COVID-19, implement effective infection prevention and control (IPC) activities, and serve as ...

The CQUIN Project for Differentiated Service Delivery

  • Multi-Country,
  • current
CQUIN is a multi-country learning network dedicated to improving differentiated service delivery (DSD) for people living with HIV. Launched in 2017 with support from the Bill & Melinda Gates Foundation, the network convenes health system leaders from countries in sub-Saharan Africa to participate in joint learning and information exchange, with the goal of fostering scale-up ...

Tracking with Recency Assays to Control the Epidemic (TRACE)

  • Multi-Country,
  • current:
  • Lesotho
Disease surveillance to stop HIV transmission in its tracks. Remarkable progress has been made toward HIV epidemic control in some high-burden countries, but many gaps remain. Identifying people with undiagnosed HIV infection, especially those who have been recently infected, is essential to realize the individual benefit of rapid treatment initiation and to prevent HIV transmission to others. ...

ICAP in Eswatini

Active Years
  • 2005 till present
Key Technical Areas
  • HIV
  • Tuberculosis
  • COVID-19
  • Antimicrobial Resistance
  • Non-communicable Diseases
  • Human Resources for Health
  • Laboratory Systems Strengthening
  • Health Systems Strengthening
  • Monitoring and Evaluation
  • One Health
  • Maternal and Child Health
  • Research
  • Surveillance
  • Training and Education
  • Technical Assistance
Current Funders
  • Bill & Melinda Gates Foundation
  • U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) / U.S. Centers for Disease Control and Prevention (CDC)
  • Family Health International 360 National Institutes of Health
  • Fleming Fund

Country Director

Ruben Sahabo, MD

Dr. Ruben Sahabo is the country director for ICAP in Eswatini. Previously, he was the ICAP country director in Rwanda, where he led the rapid expansion of care and treatment activities, overseeing technical and financial assistance to over 50 urban and rural clinics that enrolled over 50,000 patients in HIV care and treatment. He also supported the start-up of ICAP’s programs in Côte d’Ivoire in 2008 and the Democratic Republic of Congo in 2010. Dr. Sahabo has managed numerous program evaluations and research studies in Rwanda and Eswatini and was co-investigator of an evaluation of the Diagnostic Chip for Infectious Diseases in Rwanda, an innovative strategy for an integrated point-of-care microfluidic-based diagnostic device based on “lab on a chip” technologies developed by Columbia University Microscale Bioengineering Laboratory.

Jobs in Eswatini

There are currently no job listings for this country. See the ICAP careers page to search all job listings.